Bioactivity:

LCZ696 is an orally bioavailable, dual angiotensin II receptor and neprilysin inhibitor for the treatment of hypertension and heart failure.

CAS nr:

936623-90-4

Purity:

98%

Molecular Weight:

915,98

SMILES:

O.O.O.O.O.[NaH+].[NaH+].[NaH+].[NaH+].[NaH+].[NaH+].CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC([O-])=O.CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC([O-])=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[n-]n1)[C@@H](C(C)C)C([O-])=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[n-]n1)[C@@H](C(C)C)C([O-])=O

Formula:

C24H29N5O3�C24H29NO5�5/2H2O�3Na

Pathway:

Endocrinology/Hormones,Metabolism,Apoptosis

Target:

RAAS,Neprilysin,Apoptosis